Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
131.73 | -10,39% | 2,75% | 333.646,57 | 2,39% | -19,03% |
|
NYSE:ABBV
AbbVie
|
163.79 | -21,82% | -11,49% | 289.231,48 | 3,84% | 7,03% |
|
SWX:NOVN
Novartis
|
93.30 | 8,23% | 21,62% | 190.369,92 | 3,53% | 4,67% |
|
NYSE:ABT
Abbott Laboratories
|
104.59 | 1,94% | 14,62% | 181.948,29 | 2,12% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
319.04 | -14,06% | -5,45% | 171.144,12 | 2,89% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.82 | 7,74% | 37,79% | 163.311,21 | 5,92% | -9,31% |
|
LSE:GSK
GSK
|
18.13 | 5,18% | 20,68% | 73.914,43 | 3,2% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.55 | 59,85% | 70,07% | 90.307,31 | 5,37% | 13,54% |
|
ASX:CSL
CSL
|
283.05 | 21,27% | 41,99% | 136.784,68 | 1,27% | 7,18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.01 | 22,18% | 31,53% | 83.479,36 | 4,55% | 0,15% |
|
XTRA:MRK
Merck KGaA
|
165.85 | 3,79% | 18,65% | 72.107,91 | 1,39% | 10,73% |
|
NYSE:BDX
Becton Dickinson and Co
|
237.29 | 14,97% | 29,05% | 68.578,34 | 1,62% | 2,09% |
|
TSE:4568
Daiichi Sankyo Company
|
5486.00 | 0% | 0% | 10.516.360,76 | 1,11% | 0% |
|
NasdaqGS:MRNA
Moderna
|
129.06 | -.111,03% | -.107,61% | 49.460,92 | 0% | 0% |
|
NSEI:SUNPHARMA
Sun Pharmaceutical Industries
|
1527.40 | -17,98% | -6,23% | 3.664.744,23 | 0,81% | 24,54% |
|
SWX:ALC
Alcon
|
80.72 | 9,08% | 24,41% | 39.907,97 | 0,3% | 8,65% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4159.00 | 0% | 0% | 6.525.195,89 | 4,66% | 0% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.78 | -47,78% | -44,41% | 19.005,71 | 0% | -2,6% |
|
NSEI:CIPLA
Cipla
|
1406.70 | 11,52% | 24,38% | 1.081.545,93 | 0,96% | 22,76% |
|
BSE:500124
Dr. Reddy's Laboratories
|
5872.35 | 16,88% | 19% | 977.652,02 | 0,68% | 24,23% |
